Carl Dambkowski insider trades

Open-market stock purchases and sales by Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc, from SEC Form 4 filings since Dec 18, 2023.

Recent trades

DateStockTradeValue
Sep 3, 2026APGE Apogee Therapeutics, IncSold (not open market)—
Sep 3, 2026APGE Apogee Therapeutics, IncSold (not open market)$2.5M
Sep 3, 2026APGE Apogee Therapeutics, IncSold (not open market)$6.1M
Sep 3, 2026APGE Apogee Therapeutics, IncSold (not open market)$6.3M
Sep 2, 2026APGE Apogee Therapeutics, IncSold (not open market)$186K
Aug 5, 2026APGE Apogee Therapeutics, IncSold$738K
Aug 5, 2026APGE Apogee Therapeutics, IncBought (not open market)$94.3K
Aug 5, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Jul 14, 2026APGE Apogee Therapeutics, IncSold (not open market)—
Jul 1, 2026APGE Apogee Therapeutics, IncSold$730K
Jul 1, 2026APGE Apogee Therapeutics, IncBought (not open market)$94.3K
Jul 1, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Jun 22, 2026APGE Apogee Therapeutics, IncSold$3.5M
Jun 12, 2026ORKA Oruka Therapeutics, IncSold$882K
Jun 11, 2026ORKA Oruka Therapeutics, IncSold$1.6M
Jun 3, 2026APGE Apogee Therapeutics, IncSold$433K
Jun 3, 2026APGE Apogee Therapeutics, IncBought (not open market)—
Jun 2, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncSold$2.2M
May 21, 2026ORKA Oruka Therapeutics, IncSold$3.2M
May 21, 2026ORKA Oruka Therapeutics, IncSold$794K
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 21, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
May 6, 2026APGE Apogee Therapeutics, IncSold$311K

Companies traded

  • APGE Apogee Therapeutics, Inc: 57 sales, last Sep 3, 2026
  • ORKA Oruka Therapeutics, Inc: 5 sales, last Jun 12, 2026

Get free alerts when Carl Dambkowski files a new trade →